BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2020
View Archived Issues
A Tau-sand forms of tau?
Read More
FDA approves IND for SFA-002 study in psoriasis
Read More
GDF-15 proposed as a biomarker for coronary artery lesions in Kawasaki disease
Read More
miR-375 and miR-3687 are potential prognostic markers in enzalutamide-treated patients with mCRPC
Read More
SARS-CoV-2 Ab cocktails binding to distinct nonoverlapping regions of S protein prevent viral escape
Read More
Zanubrutinib demonstrates durable responses in patients with marginal zone lymphoma
Read More
RevImmune launches phase II U.K. study of CYT-107 for COVID-19
Read More
Preclinical studies show promise of GLP-1R agonist GL-0034 for treating diabetes
Read More
Japanese approval for Samsca for hyponatremia secondary to SIADH in adults
Read More
Shape-shifting DENV3 evades vaccines, therapeutics
Read More
Interim data reported from phase I study of INO-4800 vaccine for COVID-19
Read More
Antag Therapeutics describes new gastric inhibitory polypeptide receptor antagonists
Read More
Topline data from pivotal CONNECT-FX study of Zygel in fragile X syndrome
Read More
Dosing completed in first dose-escalation cohorts of phase I/II study of RTX-240
Read More
New galectin-3 inhibitors discovered at Bristol-Myers Squibb
Read More
Novartis patents chondrogenesis inducers
Read More
Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group disclose S1P1 agonists
Read More
New PI3K inhibitors identified at Innovent Biologics
Read More
Researchers present preclinical data on EDIT-301 for sickle cell disease
Read More
Exelixis initiates phase III CONTACT-02 study of cabozantinib plus atezolizumab in CRPC
Read More
Ilumya approved in Japan for plaque psoriasis
Read More
Hoth enters sponsored research agreement with VCU for potential peptide COVID-19 therapeutic
Read More
Bavencio approved in U.S. as first-line maintenance in urothelial carcinoma
Read More
Innovent Biologics' bispecific antibody IBI-323 blocks PD-L1 and LAG-3
Read More
Amniox begins first phase III trial of TTAX-01 in diabetic foot ulcers
Read More
Lysogene collaborates with Weizmann Institute of Science on gene therapy for Gaucher and Parkinson's
Read More
FDA approves Dojolvi for long-chain fatty acid oxidation disorders
Read More
Corcept opens phase III study of relacorilant with nab-paclitaxel for metastatic pancreatic cancer
Read More